A research team at Cincinnati Children’s Hospital Medical Center has received a $150,000 grant to repurpose Barasertib as a potential treatment for Idiopathic Pulmonary Fibrosis. Using a computational drug discovery pipeline coupled with preclinical validation studies, Anil Jegga, DVM, MRes,
A research team at Cincinnati Children’s Hospital Medical Center has received a $626,000 grant to test saracatinib (AZD0530), an experimental drug, as a new potential treatment for cystic fibrosis (CF). The grant will support further preclinical evaluation of this new
Alex Jiang is currently a sophomore at Cornell University majoring in Computer Science with a minor in Cognitive Science. In 2017, he participated in the Summer Undergraduate Research Fellowship (SURF) Program at Cincinnati Children’s under the mentorship of Anil Jegga,
October 23, 2017—Researchers at Cincinnati Children’s Hospital Medical Center are combining machine learning and systems biology to distinguish disease severity in idiopathic pulmonary fibrosis (IPF), a lung disease that kills an estimated 40,000 people annually in the United States. Using